anti anemia drug final get close circul magic potion clear liquid pack vial kept refriger thousand oak warehous sit wait sold latest biotechnolog drug call erythropoietin epo anti anemia treatment seven year 70 million research develop first commerci product compani call amgen product altern said georg rathmann amgen chairman amgen get fast start run materi unaccept said gordon binder amgen chief execut amgen new manufactur plant run turn three month suppli epo amgen hire salespeopl line refriger warehous around countri keep drug fresh everyth readi save one thing amgen still need u food drug administr approv sell drug one expect fda reject amgen request sell epo hormon trigger product red blood cell clinic test success treat chronic anemia suffer patient kidney diseas epo discov scientist 1906 bodi produc microscop amount hormon challeng get enough abl make drug biotechnolog scientist medic detect resplic gene carri blueprint life trigger product rare hormon protein use therapeut drug amgen submit 40 000 page support document conduct extens epo test patient win glow review new england journal medicin amgen execut hope fda would complet elabor review approv epo sale late 1988 compani optimist drug approv sale march binder said wait amgen stock bounc scrap news fda approv process financi analyst still expect amgen first compani win approv sell epo appli fda year ahead compani approv come rich unnerv though one seem certain plenti rich novemb amgen stock spurt analyst shearson lehman hutton predict worldwid sale epo 3 5 billion 1 8 billion unit state 1993 binder said figur preposter find hard accept plan drug sell 1 billion matter cure said excit amgen last week montgomeri secur analyst denis gilbert made project epo would sell 450 million unit state 1993 stock dip excit amgen find epo compel stori tri deflat expect said troubl stock market lost much confid biotechnolog fear compani hundr actual produc drug big winner amgen much risk compani five drug undergo test human epo secur littl compani reput boost valu amgen stock 550 million even though essenti without product sell last year amgen earn 1 7 million sale 53 million figur mirag sale primarili advanc compani research develop partner profit invest stock market also pessimist biotechnolog mani misadventur genentech san francisco biotech compani whose reput took terribl beat last year year ago genentech stock trade 47 per share end enthusiasm latest drug tpa anti blood clot agent could save heart attack victim drug would sell 400 million first year analyst boast genentech execut noth discourag expect genentech end sell 175 million worth tpa 1988 still record first year sale new drug stock collaps languish 17 went wrong drug expens 2 200 dose tpa 10 time price older heart attack drug variou studi inconclus tpa advantag drug last month genentech wrote 25 million worth tpa inventori drug perish sale far slower compani optimist project binder say learn genentech troubl want spend money make someth go use industri big sale mark price possibl pharmaceut lesson 2 binder said tri reason expect amgen result gilbert recent trim 1990 profit estim amgen compani execut told would need spend get epo market still analyst figur amgen big winner epo biggest use help treat patient undergo kidney dialysi cleans impur blood patient cannot produc enough red blood cell mani need transfus four quart blood month patient inject epo need transfus abl go live normal encourag compani come drug treat rel rare diseas congress award call orphan drug statu seven year exclus franchis first manufactur drug epo qualifi orphan drug amgen shrewdli kept right sell epo kidney dialysi patient jim mccamant editor medic technolog stock letter say like 200 million year market countri possibl use epo may also work treat kind anemia includ chemotherapi leukemia patient epo also test azt aid treatment drug produc anemia side effect sale epo patient kidney diseas would open compani version epo analyst agre big market johnson amp johnson sell amgen version epo dispar use countri pay amgen royalti estim analyst 8 gross sale gilbert reckon amgen profit grow like weed 15 million march 1990 fiscal year 83 million 1993 figur amgen second drug g csf produc white blood cell strike gold well even amgen win epo race laboratori marketplac must still win battl wit courtroom ensur profit amgen lock four patent infring lawsuit chief rival genet institut biotech compani chugai pharmaceut tokyo race get version epo approv sale unit state analyst figur genet institut headquart cambridg mass least year behind amgen amgen genet institut separ seemingli conflict patent relat epo could take year case go way u court appeal case resolv compani free sell new drug whichev compani win court figur take home biggest share profit genet institut will discuss court settlement amgen presum sort cross licens deal could sell drug amgen execut refus far apart noth discuss binder said